What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Internal medicine, Endocrinology, Cancer research, Receptor and Molecular biology.
In his work, Biochemistry and Cytokine is strongly intertwined with Cell biology, which is a subfield of Internal medicine.
His Endocrinology research is multidisciplinary, incorporating perspectives in Cell culture, Autocrine signalling, Epithelium, Apoptosis and Cellular localization.
His Cancer research research is multidisciplinary, relying on both Cancer, Breast cancer, Metastasis, Cell growth and Estrogen receptor alpha.
His Receptor research includes elements of Cerebral cortex, Growth hormone receptor, In situ hybridization and Cerebellum.
Within one scientific family, Peter E. Lobie focuses on topics pertaining to Phosphorylation under Molecular biology, and may sometimes address concerns connected to Chinese hamster ovary cell, Transcription factor and Kinase.
His most cited work include:
- Signal transduction via the growth hormone receptor. (227 citations)
- Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. (200 citations)
- Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. (172 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cancer research, Internal medicine, Endocrinology, Autocrine signalling and Cell growth.
His work carried out in the field of Cancer research brings together such families of science as Cancer, Breast cancer, Metastasis, Cell and Apoptosis.
His work deals with themes such as Molecular biology and Doxorubicin, which intersect with Apoptosis.
Peter E. Lobie has included themes like Receptor, Cell culture and Signal transduction in his Endocrinology study.
Peter E. Lobie combines subjects such as Human growth hormone and Paracrine signalling with his study of Autocrine signalling.
The study incorporates disciplines such as Trefoil factor 3, Epithelial–mesenchymal transition, Cell migration, Cancer stem cell and Matrigel in addition to Cell growth.
He most often published in these fields:
- Cancer research (66.08%)
- Internal medicine (34.98%)
- Endocrinology (31.45%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (66.08%)
- Cancer (24.03%)
- Breast cancer (16.61%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Cancer, Breast cancer, Cell growth and Protein kinase B.
His study in Cancer research is interdisciplinary in nature, drawing from both Trefoil factor 3, Cancer cell, Downregulation and upregulation, Metastasis and Phosphorylation.
His Phosphorylation research also works with subjects such as
- Apoptosis and related Cell culture, Doxorubicin and Signal transduction,
- Viability assay which intersects with area such as Molecular biology.
His biological study spans a wide range of topics, including Autophagy, Precision medicine, Computational biology and Kinase.
Breast cancer is a subfield of Internal medicine that he studies.
His study looks at the relationship between Cell growth and topics such as Cell migration, which overlap with Paracrine signalling, Lung cancer and Gene silencing.
Between 2017 and 2021, his most popular works were:
- Triple negative breast cancer in Asia: An insider's view. (68 citations)
- Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades (42 citations)
- NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression (34 citations)
In his most recent research, the most cited papers focused on:
Peter E. Lobie mostly deals with Cancer research, Cancer, Metastasis, Apoptosis and Phosphorylation.
The Angiogenesis research Peter E. Lobie does as part of his general Cancer research study is frequently linked to other disciplines of science, such as Complement factor I, therefore creating a link between diverse domains of science.
His work in Angiogenesis addresses issues such as Vascular endothelial growth factor, which are connected to fields such as Cell culture.
The various areas that Peter E. Lobie examines in his Cancer study include Autophagy and Inhibitor of apoptosis.
Peter E. Lobie has researched Metastasis in several fields, including Gene knockdown, Cell growth, PSMB2, Carcinogenesis and Breast cancer.
His Apoptosis research integrates issues from Molecular biology and In vitro.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
